OXA-427, a new plasmid-borne carbapenem-hydrolysing class D β-lactamase in Enterobacteriaceae
Author(s) -
Pierre Bogaerts,
Thierry Naas,
Veroniek Saegeman,
Rémy A. Bonnin,
Annette Schuermans,
Stéphanie Evrard,
Warda Bouchahrouf,
Thomas Jové,
Didier Tandé,
Xavier De Bolle,
Te-Din Huang,
Laurent Dortet,
Y. Glupczynski
Publication year - 2017
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkx184
Subject(s) - ceftazidime , imipenem , microbiology and biotechnology , aztreonam , plasmid , biology , enterobacteriaceae , meropenem , escherichia coli , acinetobacter , carbapenem , cephalosporin , antibiotic resistance , antibiotics , gene , bacteria , genetics , pseudomonas aeruginosa
To describe a novel plasmid-borne class D carbapenemase (CHDL) named OXA-427 identified in several Enterobacteriaceae clinical isolates from nine patients in one Belgian hospital.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom